| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/14/2004 | CN1488641A Polypeptide medicine for inhibiting SARS coronavirus, and derivatives and use thereof |
| 04/14/2004 | CN1145798C In vitro method for determining presence of hepatocellular carcindoma |
| 04/14/2004 | CN1145698C Synthetic insecticide crystalline protein gene |
| 04/14/2004 | CN1145697C 治疗和诊断组合物 Therapeutic and diagnostic compositions |
| 04/14/2004 | CN1145696C Antifungal proteins |
| 04/14/2004 | CN1145695C Antifungal protein |
| 04/14/2004 | CN1145694C Novel human thrombopoietin mutein |
| 04/14/2004 | CN1145693C Amino-terminally truncated MCP-2 as chemokine antagnosits |
| 04/14/2004 | CN1145692C Hypersensitive response induced resistance in plants by seed treatment |
| 04/14/2004 | CN1145691C Production of water stress or salt stress tolerant transgenic cereal plants |
| 04/14/2004 | CN1145642C Method for separating and/or isolating plasma proteins by annularchromatography |
| 04/14/2004 | CN1145641C Monomeric insulin analog formulations |
| 04/14/2004 | CN1145640C Flocculation air-floating process for extracting yeast protein |
| 04/14/2004 | CN1145639C Subunit respiratory syncytial virus vaccine preparation |
| 04/13/2004 | US6720488 Transgenic maize seed and method for controlling insect pests |
| 04/13/2004 | US6720479 Plant retroelements and methods related thereto |
| 04/13/2004 | US6720478 RAD51-like polynucleotide and uses thereof |
| 04/13/2004 | US6720477 Generation of stress resistant food crops |
| 04/13/2004 | US6720476 CTR1 homologue from melon |
| 04/13/2004 | US6720472 Therapy for use in the treatment of obesity; obtain mammal, administer dietetic modulating agent, monitor adjustment in weight |
| 04/13/2004 | US6720415 S-ribosylhomocysteine to homocysteine; bacterial genes involved in biosynthesis of the signaling molecule; bacterial autoinducer-2 signaling molecule; luminescence in the vibrio harveyi signaling system 2 bioassay; luxq luminescence genes |
| 04/13/2004 | US6720413 Methods and compositions for diagnosis and treatment of cancer |
| 04/13/2004 | US6720412 Can be used in therapeutic, diagnostic, and pharmacogenomic applications. |
| 04/13/2004 | US6720410 Nucleic acids encoding enamel matrix related polypeptides |
| 04/13/2004 | US6720409 Anti-human influenza virus antibody |
| 04/13/2004 | US6720408 Generation of preferential nucleotide sequences library; obtain nucleotide sequences, denature, hybridize to primers, remove and recover nucleotide sequences expressing signal |
| 04/13/2004 | US6720355 Antiseptics; acidity ph; destroying infections |
| 04/13/2004 | US6720311 To cause apoptosis in colon cancer and prostate cancer cells |
| 04/13/2004 | US6720183 Cytoplasmic inhibition of gene expression |
| 04/13/2004 | US6720182 Alternative splice variants of CD40 |
| 04/13/2004 | US6720180 Epsin 3, a novel protein closely related to, but distinct from previously described epsins. this protein plays an important role in activated epithelial cells during tissue morphogenesis. |
| 04/13/2004 | US6720175 Mediating receptor-activated or ion channel-mediated intracellular calcium mobilization or concentration. |
| 04/13/2004 | US6720172 Nucleic acid fragment encoding a sulfite reductase |
| 04/13/2004 | US6720168 2,5-diketo-d-gluconic acid (2,5-dkg); nucleotides encoding the enzyme; useful in biosynthesis of ascorbic acid |
| 04/13/2004 | US6720167 Nucleic acid sequence comprising in order a b. thuringiensis cry promoter; a bacteria stab-si sequence, a ribosome binding site, and a sequence encoding one or both proteins of a b. sphaericus binary toxin. |
| 04/13/2004 | US6720166 Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 04/13/2004 | US6720159 88KDA tumorigenic growth factor and antagonists |
| 04/13/2004 | US6720158 Splice variants of BRCA1 |
| 04/13/2004 | US6720154 Identifying a drug that enhances the ability of adjacent stat protein dimers to interact |
| 04/13/2004 | US6720151 Therapeutic agents that inhibit the tup1 pathway |
| 04/13/2004 | US6720146 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer |
| 04/13/2004 | US6720141 Diagnostics and therapeutics for restenosis |
| 04/13/2004 | US6720139 Genes identified as required for proliferation in Escherichia coli |
| 04/13/2004 | US6719983 VMP-like sequences of pathogenic Borrelia |
| 04/13/2004 | US6719982 Transcriptional activation is prevented; nervous system disorders; gene therapy; genetic engineering and expression |
| 04/13/2004 | US6719981 Stable, attenuated rabies virus mutants and live vaccines thereof |
| 04/13/2004 | US6719980 Vaccines, diagnostic kits, veterinary medicine |
| 04/13/2004 | US6719979 Avian-paramyxovirus nucleotide sequences for use in the detection and treatment of avian viral diseases |
| 04/13/2004 | US6719978 Virus-like particles for the induction of autoantibodies |
| 04/13/2004 | US6719976 Administering monomolecular multi-epitope peptide prepared by binding t-cell epitope regions derived from different allergens |
| 04/13/2004 | US6719975 Immunogenic polymerized hirudin in the absence of carrier protein; vaccines |
| 04/13/2004 | US6719974 Heat shock protein-based vaccines and immunotherapies |
| 04/13/2004 | US6719972 Induce antigen specific apoptosis in activated t cells; ligands with monoclonal anti-ctla4 antibody that binds to an epitope of ctla4 |
| 04/13/2004 | US6719971 Method for making humanized antibodies |
| 04/13/2004 | US6719968 For therapy of tendinitis, or other tendon or ligament defect |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/08/2004 | WO2004029631A2 Method for identifying bhs-specific proteins and fragments thereof |
| 04/08/2004 | WO2004029626A1 Regulation of human p2y15 g protein-coupled receptor |
| 04/08/2004 | WO2004029621A2 Tcell mediator/modulator assay based upon tcell restricted transgenic mouse |
| 04/08/2004 | WO2004029576A2 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 04/08/2004 | WO2004029575A2 Methods for diagnosing htlv-i-mediated diseases |
| 04/08/2004 | WO2004029295A1 Method for diagnosis of cancer |
| 04/08/2004 | WO2004029287A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/08/2004 | WO2004029280A2 Anti-hla assay and methods |
| 04/08/2004 | WO2004029276A2 Nucleic acids encoding a mammalian raptor polypeptide and uses therefor |
| 04/08/2004 | WO2004029274A2 Method for generating an immune response and reagents therefor |
| 04/08/2004 | WO2004029248A1 Tumor antigen protein and utilization thereof |
| 04/08/2004 | WO2004029247A1 Nuclear receptor transcriptional corepressor and uses thereof |
| 04/08/2004 | WO2004029246A2 Integrase cofactor |
| 04/08/2004 | WO2004029245A1 Method for designing peptides |
| 04/08/2004 | WO2004029243A1 Method of predicting genetic risk for hypertension |
| 04/08/2004 | WO2004029231A1 Compositions and methods for amplification of human stem cells |
| 04/08/2004 | WO2004029224A2 Methods of engineering spatially conserved motifs in polypeptides |
| 04/08/2004 | WO2004029222A2 Pathogen-responsive genes, promoters, regulatory elements, and methods of use for same |
| 04/08/2004 | WO2004029218A2 Receptors and membrane-associated proteins |
| 04/08/2004 | WO2004029209A2 Epitope-tagged recombinant growth arrest specific gene 6 protein |
| 04/08/2004 | WO2004029206A2 Targeted cd1d molecules |
| 04/08/2004 | WO2004029205A2 Structural and cytoskeleton-associated proteins |
| 04/08/2004 | WO2004029201A2 Peptide derivative fusion inhibitors of hiv infection |
| 04/08/2004 | WO2004029200A2 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 04/08/2004 | WO2004029199A2 A set of ubiquitous cellular proteins involved in viral life cycle |
| 04/08/2004 | WO2004029197A2 Co-stimulatory molecules |
| 04/08/2004 | WO2004029135A2 Gluten biopolymers |
| 04/08/2004 | WO2004029090A1 Human coagulation factor vii polypeptides |
| 04/08/2004 | WO2004029089A2 Novel angiogenesis target and uses thereof |
| 04/08/2004 | WO2004029088A2 Multidrug resistance proteins in drosophila and anopheles |
| 04/08/2004 | WO2004029087A2 Bitter taste receptors |
| 04/08/2004 | WO2004029086A2 Regulation of human calcium-independent alpha-latrotoxin receptor homolog 3 |
| 04/08/2004 | WO2004029085A2 METHOD FOR THE RATIONAL MUTAGENESIS OF A/ss T CELL RECEPTORS AND CORRESPONDINGLY MUTATED MDM2 PROTEIN-SPECIFIC A/ss T-CELL RECEPTORS |
| 04/08/2004 | WO2004029084A2 Lipase inhibitors and uses thereof |
| 04/08/2004 | WO2004029083A1 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen phl p 7 |
| 04/08/2004 | WO2004029082A1 Antibacterial substance produced by lactic acid bacterium |
| 04/08/2004 | WO2004029081A2 Modified glp-1 peptides with increased biological potency |
| 04/08/2004 | WO2004029077A2 Method for producing acylated peptides |
| 04/08/2004 | WO2004029076A2 Purification process comprising microfiltration at elevated temperatures |
| 04/08/2004 | WO2004029075A2 Peptide nucleic acids having improved uptake and tissue distribution |
| 04/08/2004 | WO2004029074A2 Hiv-derived hr1 peptides modified to form stable trimers, and their use in therapy to inhibit transmission of human immunodeficiency virus |
| 04/08/2004 | WO2004029073A2 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 04/08/2004 | WO2004029071A2 Mage-c2 antigenic peptides and uses thereof |
| 04/08/2004 | WO2004029023A2 Cell-surface estrogen receptor and related compositions and methods |